Skip to main content
. 2022 May;11(5):776–785. doi: 10.21037/tlcr-22-320

Figure 1.

Figure 1

Kaplan-Meier estimates of overall survival and progression-free survival in patients with and without EGFR mutation. (A) Overall survival of patients with and without EGFR mutation; (B) progression-free survival of patients with and without EGFR mutation. EGFR, epidermal growth factor receptor.